BIFIFOLIC

USPTO USPTO 2007 IR CANCELLED; US REGISTRATION CANCELLED

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die US-Marke BIFIFOLIC wurde als Wortmarke am 19.01.2007 beim Amerikanischen Patent- und Markenamt angemeldet.
Sie wurde am 08.04.2008 im Markenregister eingetragen. Der aktuelle Status der Marke ist "IR CANCELLED; US REGISTRATION CANCELLED".

Markendetails

Markenform Wortmarke
Aktenzeichen 79036294
Registernummer 3409418
Anmeldedatum 19. Januar 2007
Veröffentlichungsdatum 22. Januar 2008
Eintragungsdatum 08. April 2008

Markeninhaber

I-28100 NOVARA

Markenvertreter

Waren und Dienstleistungen

1 Fermentation extracts and bacteria for use in food manufacture, namely, micro-organisms and cultures of micro-organisms, in particular bacteria and bifidobacteria; fermentation extracts and bacteria for use in food manufacture, namely, micro-organisms and cultures of micro-organisms, in particular probiotic lactic acid bacteria, probiotic bifidobacteria for administering to humans and to animal livestock species, not for medical or veterinary use; fermentation extracts and bacteria for use in food manufacture, namely, micro-organisms and concentrated cultures of probiotic micro-organisms in liquid, solid, dried or freeze-dried form
5 Bacterial and bacteriological preparations for medical or veterinary purposes, namely, micro-organisms and cultures of micro-organisms, in particular probiotic lactic acid bacteria and probiotic bifidobacteria for administering to humans and to animal livestock species; proprietary medicines for the treatment or elimination of bacteria, fungi and viruses present in tissue, on the skin and in mucous membranes, containing micro-organisms and cultures of micro-organisms; food supplements, food supplements for medical use containing micro-organisms or cultures of microorganisms, in particular probiotic lactic acid bacteria, probiotic bifidobacteria for administering to humans; dietetic supplements; proprietary medicines containing lactic acid bacteria and bifidobacteria, in particular lactic ferments, probiotic micro-organisms or cultures of micro-organisms, for the treatment of intestinal bacterial flora, to restore the balance of intestinal bacterial flora altered during courses of antibiotic therapy or chemotherapy, for the treatment of acute and chronic gastro-intestinal problems caused by an alteration in the intestinal bacterial flora, for the treatment of intestinal dismicrobian syndromes, in particular in pathologies linked to alterations in bacterial flora such as diarrhea, gastroenteritis, non-specific enteritis, colitis, ulcerous colitis and Crohn's disease, for the production of vitamins, in particular of vitamin B12 or folic acid in the gastro-intestinal segment, and for stimulating intestinal bacterial flora to produce vitamins, in particular vitamin B12 or folic acid, all in the forms of capsules, tablets, solutions, suspensions, granules, or granules in dried or freeze-dried form
29 Fermented products and milk, namely, yogurt, cheese, milk and soy-based food beverage for use as a milk substitute, rice milk for use as a milk substitute; proteins being foodstuffs for human consumption, not for medical use, containing micro-organisms and micro-organism cultures, in particular probiotic lactic acid bacteria and probiotic bifidobacteria; proteins being foodstuffs for human consumption containing micro-organisms or cultures of micro-organisms, in particular probiotic lactic acid bacteria, probiotic bifidobacteria and prebiotic fibers
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

ID: 1379036294